$ Value
$0
Shares
1,373
Price
$0
Filed
May 5
Insider
Name
Lenkowsky Adam
Title
EVP, Chief Commercial Officer
CIK
0001975719
Roles
Transaction Details
Transaction Date
2025-05-01
Code
J
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,748
Footnotes
Based on recent 401(k) plan statement. | The total number of securities owned by the reporting person's spouse is updated to correct an administrative error in the previous Form 4. | Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. | Represents the cancellation of one-quarter of market share units granted on May 1, 2023 due to the 80% minimum payout factor not being achieved. | Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.
Filing Info
Lenkowsky Adam's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | BMY | M | $0 |
| 2026-03-10 | BMY | J | $0 |
| 2026-03-10 | BMY | F | $50K |
| 2026-03-10 | BMY | M | $0 |
| 2026-03-10 | BMY | J | $0 |
| 2026-03-10 | BMY | F | $55K |
| 2026-03-10 | BMY | M | $0 |
| 2026-03-10 | BMY | J | $0 |
| 2026-03-10 | BMY | F | $188K |
| 2026-03-10 | BMY | M | $0 |
Other Insiders at BMY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| YALE PHYLLIS R | — | — | 2026-03-31 |
| Arduini Peter J | — | — | 2026-03-31 |
| Rice Derica W | — | — | 2026-03-31 |
| Price Paula A | — | — | 2026-02-01 |
| McMullen Michael R. | — | — | 2026-03-31 |
|
Elkins David V
EVP, Chief Financial Officer
|
— | $1.9M | 2026-04-01 |
|
BOERNER CHRISTOPHER S.
Chief Executive Officer
|
— | — | 2026-03-10 |
| Haller Julia A | — | — | 2026-02-01 |
| Samuels Theodore R. II | — | — | 2026-03-31 |
| Vousden Karen H | — | — | 2026-02-01 |
|
Hickey Benjamin
President, RayzeBio Org.
|
— | — | 2026-03-10 |
|
Plenge Robert M
EVP, Chief Research Officer
|
— | — | 2026-03-10 |
| Hidalgo Medina Manuel | — | — | 2026-02-01 |
|
Meyers Gregory Scott
EVP, Chief Digital & Tech Off.
|
— | — | 2026-03-10 |
|
Shanahan Karin
EVP, Chief Supply Chain & Ops
|
— | — | 2026-04-01 |
| Bhatt Deepak | — | — | 2026-02-01 |
|
Lenkowsky Adam
EVP, Chief Commercial Officer
|
— | — | 2026-03-10 |
|
Gallman Cari
EVP, General Counsel
|
— | — | 2026-03-10 |
|
Poole Ahn Amanda
EVP, Chief People Officer
|
— | — | 2026-03-10 |
|
Hoch Lynelle
President, Cell Therapy Org.
|
— | — | 2026-03-10 |
|
Holzer Phil M
SVP and Controller
|
— | — | 2026-03-10 |
|
Short Bartie Wendy
EVP, Corporate Affairs
|
— | — | 2026-03-10 |
|
Shibutani Hiroshi Chris
EVP, Chief Strategy Officer
|
— | — | 2026-03-10 |
|
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
|
— | — | 2026-03-10 |